Calcitriol and lexicalcitol (KH1060) inhibit the growth of human breast adenocarcinoma cells by enhancing transforming growth factor-β production

Biochemical Pharmacology

Volumn 52, Issue 3, 1996, Pages 505-510

  Mercier, Thierry ^a   Chaumontet, Catherine ^a   Gaillard Sanchez, Isabelle ^a   Martel, Paule ^a   Heberden, Christine ^a  

^a CEMAGREF   (France)

Author keywords

1,25 dihydroxyvitamin D3; calcitriol; KH1060; MCF 7 cells; TGF

Indexed keywords

CALCITRIOL; LEXACALCITOL; MESSENGER RNA; NEUTRALIZING ANTIBODY; RNA; TRANSFORMING GROWTH FACTOR BETA;

ARTICLE; BREAST ADENOCARCINOMA; CANCER INHIBITION; CELL GROWTH; CELL PROLIFERATION; CELL STRAIN MCF 7; CONCENTRATION RESPONSE; CONTROLLED STUDY; DOSE TIME EFFECT RELATION; DRUG INHIBITION; DRUG MECHANISM; HUMAN; NORTHERN BLOTTING; PRIORITY JOURNAL;

EID: 0030576653     PISSN: 00062952     EISSN: None     Source Type: Journal    
DOI: 10.1016/0006-2952(96)00254-7     Document Type: Article

References (46)

1. 1. Attisano L, Wrana JL, Lopez-Casillas F and Massagué J, TGF-β receptors and actions. Biochim Biophys Acta 1222: 71-80, 1994.
2. 2. Rotello RJ, Lieberman RC, Purchio AF and Gerschenson LE, Coordinated regulation of apoptosis and cell proliferation by transforming growth factor-β1 in cultured uterine epithelial cells. Proc Nat Acad Sci USA 88: 3412-3415, 1991.
3. 3. Oberhammer F, Bursh W, Tiefenbacher R, Froschl G, Pavelka M, Purchio T and Schulte-Hermann R, Apoptosis is induced by transforming growth factor-β1 within 5 hours in regressing liver without significant fragmentation of DNA. Hepatology 18: 1238-1246, 1993.
4. 4. Fukuda K, Kojiro M and Chiu JF, Induction of apoptosis by transforming growth factor-β1 in the rat hepatoma cell line McA-RH7777: a possible association with tissue transglutaminase expression. Hepatology 18: 945-953, 1993.
5. 5. Wu SP, Sun LZ, Willson JKV, Humphrey L, Kerbel R and Brattain MG, Repression of autocrine transforming growth factor-β1 and β2 in quiescent CBS colon carcinoma cells leads to progression of tumorigenic properties. Cell Growth Differ 4: 115-123, 1993.
6. 6. Glick AB, Kulkarni AB, Tennenbaum T, Hennings H, Flanders KC, O'Reilly M, Sporn MB, Karlsson S and Yuspa SH. Loss of expression of transforming growth factor-β in skin and skin tumors is associated with hyperproliferation and a high risk for malignant conversion. Proc Nat Acad Sci USA 90: 6076-6080, 1993.
7. 7. Wright JA, Turley EA and Greenberg AH, Transforming growth factor beta and fibroblast growth factor as promoters of tumor progression to malignancy. Crit Rev Oncog 4: 473-492, 1993.
8. 8. Arteaga CL, Hurd SD, Winnier AR, Johnson MD, Fendly BM and Forbes JT, Anti-transforming growth factor (TGF-β) antibodies inhibit breast cancer cell tumorigenicity and increase mouse spleen natural killer cell activity: implications for a possible role of tumor cell/host TGF-β interactions in human breast cancer progression. J Clin Invest 92: 2569-2576, 1993.
9. 9. Li X, Nagayasu H, Hanada J, Hoskawa M and Takeichi N, Enhancement of tumorigenicity and invasion capacity of rat mammary adenocarcinoma cells by epidermal growth factor and transforming growth factor-β. Jpn J Cancer Res 84: 1145-1149, 1993.
10. 10. Reichel H, Koffler HP and Norman AW, The role of vitamin D endocrine system in health and disease. N Eng J Med 320: 980-991, 1989.
11. 11. Chouvet C, Vicard E, Devonec M and Saez S, 1,25-dihydroxyvitamin D3 inhibitory effect on the growth of two human breast cancer cell lines (MCF-7, BT-20). J Steroid Biochem 24: 373-376, 1986.
12. 12. Colston KW, Berger U and Coombes RC, Possible role for vitamin D in controlling breast cancer cell proliferation. Lancet 1: 188-191, 1989.
13. 13. Bickle DD, Clinical counterpoints: vitamin D: new actions, new analogs, new therapeutic potentials. Endoc Rev 13: 765-784, 1992.
14. 14. Knabbe C, Lippman ME, Wakefield LM, Flanders KC, Kasid A, Derynck R and Dickson RB, Evidence that transforming growth factor-β is a hormonally regulated negative growth factor in human breast cancer cells. Cell 196: 487-493, 1987.
15. 15. Zugmaier G, Ennis BW, Deschauer B, Katz D, Knabbe C, Wilding G, Daly P, Lippman ME and Dickson RB, Transforming growth factor type-β1 and -β2 are equipotent growth inhibitors of human breast cancer cell lines. J Cell Physiol 141: 353-361, 1989.
16. 16. Arrick BA, Korc M and Derynck R, Differential regulation of expression of three transforming growth factor-β species in human breast cancer cell lines by estradiol. Cancer Res 50: 299-303, 1990.
17. 17. Colletta AA, Wakefield LM, Howell FV, Danielpour D, Baum M and Sporn MB, The growth inhibition of human breast cancer cells by a novel synthetic progestin involves the induction of transforming growth factor-β. J Clin Invest 87: 277-283, 1991.
18. 18. Colletta AA, Wakefield LM, Howell FV, Van Roozendaal KEP, Danielpour D, Ebbs SR, Sporn MB and Baum M, Antiestrogens induce the secretion of active transforming growth factor-β from human foetal fibroblasts. Br J Cancer 62: 405-409, 1990.
19. 19. Perry RR, Kang Y and Greaves BR, Relationship between tamoxifen-induced transforming growth factor beta (1) expression, cytostasis and apoptosis in human breast cancer cells. Br J Cancer 72: 1441-1446, 1995.
20. 20. Binderup L, Latini S, Binderup E, Bretting C, Calverley M and Hansen K, 20-epi-vitamin D3 analogues: a novel class of potent regulators of cell growth and immune responses. Biochem Pharmacol 42: 1569-1575, 1991.
21. 21. Lawrence DA, Pircher R and Jullien P, Conversion of a high molecular weight latent TGF-β from chicken embryo fibroblasts into a low molecular weight active TGF-β under acidic conditions. Biochem Biophys Res Commun 133: 1026-1034, 1985.
22. 22. Absher M, Baldor L and Kelley J, A rapid colorimetric bioassay for transforming growth factor-β (TGF-β) using a microwell plate reader. J Immunol Methods 138: 301-303, 1991.
23. 23. Chomczynski P and Sacchi N, Single-step method of RNA isolation by acid guanidium thiocyanate-pnenol-chloroform extraction. Anal Biochem 162: 156-159, 1987.
24. 24. Chirgwin JM, Przybyla AE, MacDonald RJ and Rutter WJ, Isolation of biologically active ribonucleic acid from sources enriched in ribonucleases. Biochemistry 19: 5294-5299, 1979.
25. 25. Kondaiah P, Van Obberghen-Schilling EV, Ludwig RL, Dhar R, Sporn MB and Roberts AB, cDNA cloning of porcine transforming growth factor-β1 mRNAs. J Biol Chem 263: 18313-18317, 1988.
26. 26. Hanks SK, Armour R, Baldwin JH, Maldonado F, Spiess J and Holley RW, Amino acid sequence of the BSC-1 cell growth inhibitor (polyergin) deduced from the nucleotide sequence of the cDNA. Proc Natl Acad Sci USA 85: 79-82, 1988.
27. 27. Raynal F, Michot B and Bachellerie JP, Complete nucleotide sequence of mouse 18 S rRNA gene: comparison with other available homologs. FEBS Lett 167: 263-268, 1984.
28. 28. Mercier T, Gaillard-Sanchez I, Martel P and Seillan-Heberden C, Constitutive overexpression of c-fos protein in rat liver epithelial cells decreases TGF-β synthesis and increases TGF-β1 receptors. Biochim Biophys Acta 1266: 64-72, 1995.
29. 29. Madisen L, Webb NR, Rose TR, Marquardt H, Ikeda T, Twardzik D, Seyedin S and Purchio AF. Transforming growth factor-β2: cDNA cloning and sequence analysis. DNA 7: 1-8, 1988.
30. 30. Jeng MH, Ten Dijke P, Iwata KK and Jordan CV, Regulation of the levels of three transforming growth factor-β mRNAs by estrogen and their effects on the proliferation of human breast cancer cells. Mol Cell Endocrinol 97: 115-123, 1993.
31. 3 inhibition of breast cancer cell proliferation. Endocrinology 119: 2284-2289, 1986.
32. 3 in HL-60 promyelocytic leukemia cells. J Biol Chem 262: 4104-4108, 1987.
33. 3 analogs correlates with inhibition of DNA synthesis and reduced calmodulin concentration. Lab Invest 55: 269-275, 1986.
34. 34. Pietenpol JA, Stein RW, Moan E, Yaciuk P, Schlegel R, Lyons RM, Pittelkov MR, Munger K, Howley PM and Moses HL, TGF-β1 inhibition of c-myc transcription and growth in keratinocytes is abrogated by viral transforming proteins with pRB binding domains. Cell 61: 777-785, 1990.
35. 3 on binding and internalization of epidermal growth factor in cultured cells. Studies on BT-20 cells using quantitative electron microscope autoradiography. Exp Cell Res 184: 329-341, 1989.
36. 1251-epidermal growth factor binding to cultured keratinocyte by antiproliferative molecules: gamma interferon, cyclosporin A, and transforming growth factor-beta. J Invest Dermatol 93: 799-803, 1989.
37. 3 is linked to dephosphorylation of the retinoblastoma gene product. Biachem Biophys Res Commun 196: 487-493, 1993.
38. 38. Laiho M, DeCaprio JA, Ludlow JW, Livingston DM and Massagué J, Growth inhibition by TGF-β linked to suppression of retinoblastoma protein phosphorylation. Cell 62: 175-185, 1990.
39. 3. Interplay with reginoid and thyroid hormone signalling. Eur J Biochem 231: 517-527, 1995.
40. 3 analogues is not mediated by inhibition of the AP-1 pathway, but may be related to promoter selectivity. Oncogene 11: 1853-1858, 1995.
41. 3 (VD) analogues MC903, EB1089, and KH1060 activate the VD receptor: homodimers show higher ligand sensitivity than heterodimers with retinoid X receptors. J Steroid Biochem Molec Biol 51: 137-142, 1994.
42. 42. Kojima S and Rifkin DN, Mechanism of retinoid-induced activation of latent transforming growth factor-β in bovine endothelial cells. J Cell Physiol 155: 323-332, 1993.
43. 43. Kojima S, Nara K and Rifkin DN, Requirement for transglutaminase in the activation of latent transforming growth factor-β in bovine endothelial cells. J Cell Biol 121: 439-448, 1993.
44. 44. Bracke M, Romijn H, Vakaet L Jr, Vyncke B, de Mets M and Mareel M, The use of spheroids in the study of invasion. In: Spheroid culture in cancer research. (Ed. Bjerkvig R.) pp 73-105. CRC Press, Boca Raton-Ann Arbor-London, 1992.
45. 45. Correc P, Xhang S, Komano O, Laurent M and Burtin P, Visualisation of the plasmin receptor on carcinoma cells. Int J Cancer 50: 767-771, 1992.
46. 46. Wahl SM, Transforming growth factor-β: the good, the bad and the ugly. J Exp Med 180: 1587-1590, 1994.